36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
18 °P sammeln
  • Broschiertes Buch

The HIV pandemic has continued to spread especially in sub Sahara Africa, while Multi drug resistance HIV has emerged rendering the current conventional treatment of HIV ineffective. There is a need for new treatment regime which is cheap, effective and not prone to resistance development by HIV. Reactive oxygen species (ROS) activates Nuclear Factor kappa B this stimulates Tissue Necrosis Factor (TNF) receptors, which activates the cytokine system including Apoptosis Signaling Kinase. In absence of seleno-enzyme GSHpx this process leads to apoptosis of CD4 T cells in Selenium Deficient HIV…mehr

Produktbeschreibung
The HIV pandemic has continued to spread especially in sub Sahara Africa, while Multi drug resistance HIV has emerged rendering the current conventional treatment of HIV ineffective. There is a need for new treatment regime which is cheap, effective and not prone to resistance development by HIV. Reactive oxygen species (ROS) activates Nuclear Factor kappa B this stimulates Tissue Necrosis Factor (TNF) receptors, which activates the cytokine system including Apoptosis Signaling Kinase. In absence of seleno-enzyme GSHpx this process leads to apoptosis of CD4 T cells in Selenium Deficient HIV positive patients. The study looks at the effect of increased selenium intake by HIV patients. This study targets HIV clinicians, medical students, community health practitioners working with HIV/AIDS patients and Health Policy Makers.
Autorenporträt
Dr. Samwel Boaz Otieno ist Epidemiologe für öffentliche Gesundheit und auf HIV-Epidemiologie spezialisiert. Derzeit ist er am AIDS-Kontrollprogramm im öffentlichen Sektor in Kenia beteiligt. Er hat einen Master of Public Health Epidemiology (2001) und einen Doktortitel in Public Health Epidemiology, beide von der School of Public Health der Kenyatta University in Kenia.